Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.584536
Title: beta-adrenoceptor subtypes involved in myocardial preconditioning and postconditioning
Author: Penson, Peter Edward
Awarding Body: Cardiff University
Current Institution: Cardiff University
Date of Award: 2009
Availability of Full Text:
Access through EThOS:
Access through Institution:
Abstract:
Ischaemia and reperfusion in the heart leads to necrotic cell death (infarction) and contractile dysfunction (stunning). Ischaemic preconditioning (non-lethal periods of ischaemia prior to a longer ischaemic episode) and postconditioning (modified reperfusion) both reduce infarct size and are thought to act via activation of reperfusion injury salvage kinase (RISK) pathways to prevent the opening of the mitochondrial permeability transition pore (MPTP) at reperfusion. Catecholamines are released centrally and locally during myocardial ischaemia and activate adrenoceptors. This investigation was concerned with the roles of p-adrenoceptor activation in preconditioning and postconditioning. Studies utilising isolated paced atrial and ventricular tissues demonstrated that preconditioning against stunning could be achieved by ischaemic preconditioning, or pre-treatment of tissues with isoprenaline, a p-adrenoceptor agonist. Both forms of protection were blocked by propranolol, a-adrenoceptor antagonist. Postconditioning was not protective in this model. A Langendorff model of regional ischaemia was used to determine effects of -adrenoceptor agonists and antagonists on infarct size. In this model, ischaemic postconditioning was blocked by timolol, a non-selective p-adrenoceptor antagonist. Formoterol, a-adrenoceptor agonist, given at reperfusion, mimicked postconditioning. The non-selective adrenoceptor agonist, adrenaline, when applied at reperfusion, worsened reperfusion contracture but had no effect on infarct size. The application of a selective-adrenoceptor antagonist (CGP-20712A) at reperfusion led to a reduction of infarct size whereas p2 (ICI-118,551) and p3 (SR-59230A) antagonists had the opposite effect. If the results are replicable in man in vivo they would be of clinical relevance because a commonly used class of drugs (p-adrenoceptor antagonists) have the potential to abrogate the protection of postconditioning. Another widely available class of drugs (P-adrenoceptor agonists) can have cardioprotective effects at reperfusion.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.584536  DOI: Not available
Share: